In summary, we demonstrated that Bbx deficiency in the whole body, as well as specifically in osteoblasts/osteocytes, increases FGF23 expression, resulting in hypophosphatemia and subsequent bone abnormalities, including mechanical weakness, shortness, and a low BMD and BV. Here, BBX is linked to hypophosphatemia.